Marcello Cattani

Xyence Capital SGR (Xyence Capital) is a venture capital firm founded in 2002 by Stefano Peroncini and Pierluigi Paracchi. The firm is headquartered in Milano, Italy.

AbbVie Srl is a biopharmaceutical company. It manufactures and distributes pharmaceutical products. The company is headquartered in Campoverde di Aprilia, Italy.

Part of Sanofi, the company is a pharmaceutical holding company based in Paris, France. According to the French company metadata, Sanofi Développement Pharma SASU functions as a holding company. The company was founded in 1995 and Mathias Thibault has been the CEO of the company since 2020.

Fondazione Toscana Life Sciences is a non-profit organization founded by and composed of public and private institutions. These institutions encompass banks, universities, provincial, municipal and educational entities. The organization was founded in 2004 and is headquartered in Sienna, Italy.

Axon Partners Group Investment SGEIC SA (Axon Partners Group) is a private equity and venture capital firm founded in 2006 by Julio Villalobos Rius. The firm is headquartered in Madrid, Spain with offices across the globe.

Lipogems International SpA engages in the provision of adipose tissue solutions for pathologies, orthopedics, general surgery, and wound care. It offers Lipogems system, a sterile single –use medical device for the closed-loop processing and transferring of autologous adipose tissue in a single surgical step. The company was founded by Carlo Tremolada in 2010 and is headquartered in Milan, Italy.

Aurora Science, invests in Italian startups. The fund invests in health technology with particular interest for biotech and pharmaceuticals. It provides equity financing for early stage investing between EUR 1 to EUR 5 million.

Altheia Science Srl develop treatment and resolving medicines for auto-immune diseases, focusing on multiple sclerosis and diabetes. The company was founded by Paolo Fiorina, Alessandra Biffi, Paolo Rizzardi, and is headquartered in Milan, Italy.

Aurora-TT Srl (AuroraTT) is an independent venture capital firm.. Guido Guidi, Gabriele Campi, Pierluigi Paracchi, Gian Paolo Maria Rizzardi and Edoardo Negroni founded the firm in 2017. The firm is headquartered in Milan, Italy.

Takis Srl is an Italian biotech company founded in November 2009 by a group of scientists from IRBM, a research center near Rome, Italy. Takis is based in Castel Romano, IT and has more than 10 years of experience in drug discovery, contributing to the validation of new targets for the treatment of chronic viral diseases and cancer, and to a number of IND/CSA filings in the areas of virology and oncology. The private company specializes in drug discovery in oncology and has expertise in vivo electro-gene-transfer, which can be used for a variety of clinically useful applications, from vaccine development to somatic gene therapy. Takis' pipeline includes four cancer vaccine candidates based on this technology. The company was founded by Luigi Aurisicchio, who has been the CEO since incorporation.